Search

Mark Hellner

Examiner (ID: 18378, Phone: (571)272-6981 , Office: P/3645 )

Most Active Art Unit
3645
Art Unit(s)
2202, 3662, 3645, 3648, 3642, 3663
Total Applications
4184
Issued Applications
3711
Pending Applications
223
Abandoned Applications
288

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5445990 [patent_doc_number] => 20090047216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Tumor vasculature markers and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/657719 [patent_app_country] => US [patent_app_date] => 2007-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 54828 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047216.pdf [firstpage_image] =>[orig_patent_app_number] => 11657719 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/657719
Tumor vasculature markers and methods of use thereof Jan 24, 2007 Abandoned
Array ( [id] => 8760091 [patent_doc_number] => 08420612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Diabetes treatment methods and drug targets therefor' [patent_app_type] => utility [patent_app_number] => 11/625795 [patent_app_country] => US [patent_app_date] => 2007-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 16152 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11625795 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/625795
Diabetes treatment methods and drug targets therefor Jan 21, 2007 Issued
Array ( [id] => 5069547 [patent_doc_number] => 20070190649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells' [patent_app_type] => utility [patent_app_number] => 11/654553 [patent_app_country] => US [patent_app_date] => 2007-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5569 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190649.pdf [firstpage_image] =>[orig_patent_app_number] => 11654553 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/654553
Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells Jan 17, 2007 Issued
Array ( [id] => 4808132 [patent_doc_number] => 20080171710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'The Redox/Fyn/c-Cbl Pathway' [patent_app_type] => utility [patent_app_number] => 11/623919 [patent_app_country] => US [patent_app_date] => 2007-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 24567 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171710.pdf [firstpage_image] =>[orig_patent_app_number] => 11623919 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/623919
The Redox/Fyn/c-Cbl Pathway Jan 16, 2007 Abandoned
Array ( [id] => 4704578 [patent_doc_number] => 20080064102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'TRANSIENTLY IMMORTALIZED CELLS FOR USE IN GENE THERAPY' [patent_app_type] => utility [patent_app_number] => 11/615845 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13725 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064102.pdf [firstpage_image] =>[orig_patent_app_number] => 11615845 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/615845
TRANSIENTLY IMMORTALIZED CELLS FOR USE IN GENE THERAPY Dec 21, 2006 Abandoned
Array ( [id] => 5079165 [patent_doc_number] => 20070122389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Stage specific follicle maturation systems' [patent_app_type] => utility [patent_app_number] => 11/642118 [patent_app_country] => US [patent_app_date] => 2006-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18790 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20070122389.pdf [firstpage_image] =>[orig_patent_app_number] => 11642118 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/642118
Stage specific follicle maturation systems Dec 19, 2006 Abandoned
Array ( [id] => 5367685 [patent_doc_number] => 20090305244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Selection, Propagation and Use of Mosaic Aneuploid Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/084750 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10034 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305244.pdf [firstpage_image] =>[orig_patent_app_number] => 12084750 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/084750
Selection, Propagation and Use of Mosaic Aneuploid Stem Cells Nov 8, 2006 Abandoned
Array ( [id] => 5367854 [patent_doc_number] => 20090305413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'MULTIPOTENT ADULT STEM CELLS HAVING AN ABILITY OF OCT4 EXPRESSION DERIVED FROM UMBILICAL CORD BLOOD AND METHOD FOR PREPARING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/095893 [patent_app_country] => US [patent_app_date] => 2006-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3722 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305413.pdf [firstpage_image] =>[orig_patent_app_number] => 12095893 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/095893
MULTIPOTENT ADULT STEM CELLS HAVING AN ABILITY OF OCT4 EXPRESSION DERIVED FROM UMBILICAL CORD BLOOD AND METHOD FOR PREPARING THE SAME Nov 6, 2006 Abandoned
Array ( [id] => 5122156 [patent_doc_number] => 20070143871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Non-human transgenic animal models for hepatocellular carcinoma' [patent_app_type] => utility [patent_app_number] => 11/556803 [patent_app_country] => US [patent_app_date] => 2006-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50701 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20070143871.pdf [firstpage_image] =>[orig_patent_app_number] => 11556803 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/556803
Non-human transgenic animal models for hepatocellular carcinoma Nov 5, 2006 Abandoned
Array ( [id] => 5271607 [patent_doc_number] => 20090075383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'COMPOSITION AND METHOD FOR EFFICIENT DELIVERY OF NUCLEIC ACIDS TO CELLS USING CHITOSAN' [patent_app_type] => utility [patent_app_number] => 12/092498 [patent_app_country] => US [patent_app_date] => 2006-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10217 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075383.pdf [firstpage_image] =>[orig_patent_app_number] => 12092498 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/092498
COMPOSITION AND METHOD FOR EFFICIENT DELIVERY OF NUCLEIC ACIDS TO CELLS USING CHITOSAN Nov 5, 2006 Abandoned
Array ( [id] => 5171294 [patent_doc_number] => 20070071725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Nitric oxide synthase gene transfer' [patent_app_type] => utility [patent_app_number] => 11/589992 [patent_app_country] => US [patent_app_date] => 2006-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12838 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20070071725.pdf [firstpage_image] =>[orig_patent_app_number] => 11589992 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/589992
Nitric oxide synthase gene transfer Oct 30, 2006 Abandoned
Array ( [id] => 4893354 [patent_doc_number] => 20080102452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Control nucleic acid constructs for use in analysis of methylation status' [patent_app_type] => utility [patent_app_number] => 11/590711 [patent_app_country] => US [patent_app_date] => 2006-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 25808 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102452.pdf [firstpage_image] =>[orig_patent_app_number] => 11590711 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/590711
Control nucleic acid constructs for use in analysis of methylation status Oct 30, 2006 Abandoned
Array ( [id] => 4893423 [patent_doc_number] => 20080102521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Stem Cell Banking System' [patent_app_type] => utility [patent_app_number] => 11/554059 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3141 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102521.pdf [firstpage_image] =>[orig_patent_app_number] => 11554059 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/554059
Stem cell banking system Oct 29, 2006 Issued
Array ( [id] => 7692658 [patent_doc_number] => 20070231375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Liposome combination and the use thereof' [patent_app_type] => utility [patent_app_number] => 11/589198 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3799 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231375.pdf [firstpage_image] =>[orig_patent_app_number] => 11589198 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/589198
Liposome combination and the use thereof Oct 29, 2006 Abandoned
Array ( [id] => 4999313 [patent_doc_number] => 20070041947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Use of a lentiviral vector in the treatment of pain' [patent_app_type] => utility [patent_app_number] => 11/588965 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20322 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20070041947.pdf [firstpage_image] =>[orig_patent_app_number] => 11588965 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/588965
Use of a lentiviral vector in the treatment of pain Oct 26, 2006 Abandoned
Array ( [id] => 5040208 [patent_doc_number] => 20070092490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'HIGH EFFICIENCY SIN VECTOR' [patent_app_type] => utility [patent_app_number] => 11/551659 [patent_app_country] => US [patent_app_date] => 2006-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7597 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092490.pdf [firstpage_image] =>[orig_patent_app_number] => 11551659 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/551659
HIGH EFFICIENCY SIN VECTOR Oct 19, 2006 Abandoned
Array ( [id] => 4675598 [patent_doc_number] => 20080213227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Mesenchymal stem cells and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/541853 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9655 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213227.pdf [firstpage_image] =>[orig_patent_app_number] => 11541853 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/541853
Mesenchymal stem cells and uses therefor Oct 1, 2006 Abandoned
Array ( [id] => 4873674 [patent_doc_number] => 20080200408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Deletion mutants of tetrodotoxin-resistant sodium channel alpha subunit' [patent_app_type] => utility [patent_app_number] => 11/540145 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23382 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200408.pdf [firstpage_image] =>[orig_patent_app_number] => 11540145 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/540145
Deletion mutants of tetrodotoxin-resistant sodium channel alpha subunit Sep 28, 2006 Abandoned
Array ( [id] => 5041160 [patent_doc_number] => 20070093442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Modulation of mesenchymal and metastatic cell growth' [patent_app_type] => utility [patent_app_number] => 11/525715 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17068 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093442.pdf [firstpage_image] =>[orig_patent_app_number] => 11525715 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/525715
Modulation of mesenchymal and metastatic cell growth Sep 21, 2006 Issued
Array ( [id] => 5040213 [patent_doc_number] => 20070092495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Methods for regulating differentiation of neural cells and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/524162 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27525 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092495.pdf [firstpage_image] =>[orig_patent_app_number] => 11524162 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/524162
Methods for regulating differentiation of neural cells and uses thereof Sep 19, 2006 Abandoned
Menu